Checkpoint Therapeutics Inc Stock Other OTC
Equities
US1628281073
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 888K | Sales 2025 * | 172M | Capitalization | 50.67M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | 61M | EV / Sales 2024 * | 57 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.29 x |
P/E ratio 2024 * |
-0.95
x | P/E ratio 2025 * |
0.99
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.32% |
Managers | Title | Age | Since |
---|---|---|---|
James Oliviero
CEO | Chief Executive Officer | 48 | 15-10-12 |
William Gray
DFI | Director of Finance/CFO | 36 | 16-01-31 |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 14-11-09 | |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Christian Béchon
BRD | Director/Board Member | 63 | 18-10-15 |
1st Jan change | Capi. | |
---|---|---|
+2.31% | 42.59B | |
+7.47% | 40.65B | |
+49.05% | 40.57B | |
-11.96% | 26.77B | |
+8.55% | 24.81B | |
-24.37% | 18.17B | |
+28.01% | 12.05B | |
-2.79% | 11.7B | |
+6.91% | 11.1B |